Shell Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Shell Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,152	Closed	-$282K	–	1276
2019 Q3	$282K	Sell	4,152 -36	-0.9%	-$2.47K	0.01%	1073
2019 Q2	$244K	Sell	4,188 -96	-2%	-$5.69K	0.01%	1087
2019 Q1	$300K	Hold	4,284	–	–	0.01%	1048
2018 Q4	$276K	Sell	4,284 -400	-9%	-$28K	0.01%	996
2018 Q3	$329K	Buy	+4,684	New	+$274K	0.01%	1052

Shell Asset Management's GHDX Position: Q4 2019 in Review

Shell Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 4,152 shares — an estimated $282K sold.

Shell Asset Management first reported a position in GHDX in Q3 2018 and held it in 5 quarters. The position peaked at $329K in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Shell Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Shell Asset Management sold 4,152 Genomic Health, Inc. shares in Q4 2019, an estimated $282K.
Shell Asset Management first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 5 quarters.
Shell Asset Management's Genomic Health, Inc. position peaked at $329K in Q3 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Shell Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.